All of the following drugs are useful in destrussor instability EXCEPT:
**Core Concept**
Detrusor instability, also known as overactive bladder, is a condition characterized by involuntary contractions of the detrusor muscle, leading to symptoms such as urinary urgency, frequency, and incontinence. The management of detrusor instability involves pharmacological interventions that target the muscarinic receptors in the bladder.
**Why the Correct Answer is Right**
The primary mechanism of action for managing detrusor instability involves the blockade of muscarinic receptors, which are responsible for the contraction of the detrusor muscle. Drugs that block these receptors, such as antimuscarinics (e.g., oxybutynin, tolterodine), are effective in reducing detrusor instability by decreasing the frequency and intensity of involuntary contractions.
**Why Each Wrong Option is Incorrect**
**Option A:** Anticholinesterases (e.g., pyridostigmine) are actually used to treat detrusor underactivity, not detrusor instability. They work by increasing the concentration of acetylcholine in the synaptic cleft, thereby enhancing the contraction of the detrusor muscle.
**Option B:** Muscarinic agonists (e.g., bethanechol) would actually worsen detrusor instability by increasing the contraction of the detrusor muscle.
**Option C:** This option is missing, so we can't evaluate it.
**Clinical Pearl / High-Yield Fact**
Antimuscarinics are a mainstay in the management of detrusor instability, but they can cause anticholinergic side effects such as dry mouth, constipation, and blurred vision. It's essential to weigh the benefits against the risks and monitor patients for these side effects.
**Correct Answer:** A. Anticholinesterases are useful in detrusor underactivity, not detrusor instability.